[{"address1": "630 5th Avenue", "address2": "20th Floor", "city": "New York", "state": "NY", "zip": "10111", "country": "United States", "phone": "844 689 3939", "website": "https://www.anavex.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States. The company's lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher U. Missling M.B.A., M.S., Ph.D.", "age": 58, "title": "President, CEO, Secretary & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 856100, "exercisedValue": 373526, "unexercisedValue": 10940450}, {"maxAge": 1, "name": "Ms. Sandra  Boenisch CPA, CGA", "age": 43, "title": "Principal Financial Officer & Treasurer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 209527, "exercisedValue": 0, "unexercisedValue": 553580}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 1, "overallRisk": 4, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.31, "open": 9.44, "dayLow": 9.23, "dayHigh": 9.5854, "regularMarketPreviousClose": 9.31, "regularMarketOpen": 9.44, "regularMarketDayLow": 9.23, "regularMarketDayHigh": 9.5854, "payoutRatio": 0.0, "beta": 0.801, "forwardPE": -14.857142, "volume": 520965, "regularMarketVolume": 520965, "averageVolume": 1015948, "averageVolume10days": 596420, "averageDailyVolume10Day": 596420, "bid": 6.77, "ask": 11.91, "bidSize": 2, "askSize": 2, "marketCap": 796200896, "fiftyTwoWeekLow": 3.51, "fiftyTwoWeekHigh": 14.441, "fiftyDayAverage": 8.8834, "twoHundredDayAverage": 7.9011, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 675425920, "profitMargins": 0.0, "floatShares": 82257080, "sharesOutstanding": 85064200, "sharesShort": 24012729, "sharesShortPriorMonth": 24042495, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.2823, "heldPercentInsiders": 0.03288, "heldPercentInstitutions": 0.35448003, "shortRatio": 18.84, "shortPercentOfFloat": 0.2912, "impliedSharesOutstanding": 85064200, "bookValue": 1.305, "priceToBook": 7.172414, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -46491000, "trailingEps": -0.55, "forwardEps": -0.63, "lastSplitFactor": "1:4", "lastSplitDate": 1444176000, "52WeekChange": 1.4375, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 9.36, "targetHighPrice": 46.0, "targetLowPrice": 15.0, "targetMeanPrice": 34.33333, "targetMedianPrice": 42.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 120775000, "totalCashPerShare": 1.42, "totalDebt": 0, "quickRatio": 9.395, "currentRatio": 9.449, "returnOnAssets": -0.24337, "returnOnEquity": -0.37722, "freeCashflow": -22235500, "operatingCashflow": -35614000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "AVXL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746229899, "regularMarketTime": 1746216001, "exchange": "NMS", "messageBoardId": "finmb_13580387", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Anavex Life Sciences Corp.", "longName": "Anavex Life Sciences Corp.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1154525400000, "postMarketChangePercent": 1.38889, "postMarketPrice": 9.49, "postMarketChange": 0.13, "regularMarketChange": 0.049999237, "regularMarketDayRange": "9.23 - 9.5854", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1015948, "fiftyTwoWeekLowChange": 5.8499994, "fiftyTwoWeekLowChangePercent": 1.6666665, "fiftyTwoWeekRange": "3.51 - 14.441", "fiftyTwoWeekHighChange": -5.0810003, "fiftyTwoWeekHighChangePercent": -0.35184547, "fiftyTwoWeekChangePercent": 143.75, "earningsTimestamp": 1739363400, "earningsTimestampStart": 1746621000, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1739367000, "earningsCallTimestampEnd": 1739367000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.55, "epsForward": -0.63, "epsCurrentYear": -0.65, "priceEpsCurrentYear": -14.4, "fiftyDayAverageChange": 0.4765997, "fiftyDayAverageChangePercent": 0.053650595, "twoHundredDayAverageChange": 1.4588995, "twoHundredDayAverageChangePercent": 0.1846451, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": 0.5370487, "regularMarketPrice": 9.36, "displayName": "Anavex Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]